Citations
Works Cited
Most, A. (1984). Bufo alvarius: the psychedelic toad of the Sonoran Desert. Venom Press.
Barsuglia, J., Davis, A. K., Palmer, R., Lancelotta, R., Windham-Herman, A. M., Peterson, K., … & Griffiths, R. R. (2018). Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study. Frontiers in Psychology, 2459. https://doi.org/10.3389/fpsyg.2018.02459
Davis, A. K., So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R. (2019). 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. The American journal of drug and alcohol abuse, 45(2), 161-169. https://doi.org/10.1080/00952990.2018.1545024
Ermakova, A. O., Dunbar, F., Rucker, J., & Johnson, M. W. (2022). A narrative synthesis of research with 5-MeO-DMT. Journal of Psychopharmacology, 36(3), 273–294. https://doi.org/10.1177/02698811211050543
Gorman, I., Nielson, E. M., Molinar, A., Cassidy, K., & Sabbagh, J. (2021). Psychedelic harm reduction and integration: a transtheoretical model for clinical practice. Frontiers in psychology, 12, 710. https://doi.org/10.3389/fpsyg.2021.645246
Lima da Cruz, R. V., Moulin, T. C., Petiz, L. L., & Leão, R. N. (2018). A single dose of 5-MeO-DMT stimulates cell proliferation, neuronal survivability, morphological and functional changes in adult mice ventral dentate gyrus. Frontiers in Molecular Neuroscience, 312. https://doi.org/10.3389/fnmol.2018.00312
Miller, M. J., Albarracin-Jordan, J., Moore, C., & Capriles, J. M. (2019). Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America. Proceedings of the National Academy of Sciences, 116(23), 11207-11212. https://doi.org/10.1073/pnas.1902174116
Nagai, F., Nonaka, R., & Kamimura, K. S. H. (2007). The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. European journal of pharmacology, 559(2-3), 132-137.https://doi.org/10.1016/j.ejphar.2006.11.075
Pochettino, M.L., Cortella, A.R. & Ruiz, M. Hallucinogenic snuff from Northwestern Argentina: Microscopical identification of anadenanthera colubrina var. cebil (fabaceae) in powdered archaeological material. Econ Bot 53, 127–132 (1999). https://doi.org/10.1007/BF02866491
Szabo A, Kovacs A, Frecska E, Rajnavolgyi E (2014) Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells. PLoS ONE 9(8): e106533. https://doi.org/10.1371/journal.pone.0106533
Uthaug, M.V., Lancelotta, R., van Oorsouw, K. et al. A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Psychopharmacology 236, 2653–2666 (2019). https://doi.org/10.1007/s00213-019-05236-w
Uthaug, M. V., Lancelotta, R., Ortiz Bernal, A. M., Davis, A. K., & Ramaekers, J. G. (2020). A comparison of reactivation experiences following vaporization and intramuscular injection (IM) of synthetic 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting, Journal of Psychedelic Studies, 4(2), 104-113. https://doi.org/10.1556/2054.2020.00123
Kargbo. (2021). 5-MeO-DMT: Potential Use of Psychedelic-Induced Experiences in the Treatment of Psychological Disorders. ACS Medicinal Chemistry Letters, 12(11), 1646–1648. https://pubs.acs.org/doi/10.1021/acsmedchemlett.1c00546
Ermakova, A. O., Dunbar, F., Rucker, J., & Johnson, M. W. (2021). A narrative synthesis of research with 5-MeO-DMT. Journal of Psychopharmacology, 02698811211050543. https://journals.sagepub.com/doi/full/10.1177/02698811211050543
Siegel, A. N., Meshkat, S., Benitah, K., Lipsitz, O., Gill, H., Lui, L. M. W., Teopiz, K. M., McIntyre, R. S., & Rosenblat, J. D. (2021, May 18). Registered clinical studies investigating psychedelic drugs for psychiatric disorders. Journal of Psychiatric Research. https://www.sciencedirect.com/science/article/abs/pii/S0022395621002880
Winne, J., Boerner, B. C., Malfatti, T., Brisa, E., Doerl, J., Nogueira, I., Leão, K. E., & Leão, R. N. (2020, January 8). Anxiety-like behavior induced by salicylate depends on age and can be prevented by a single dose of 5-MEO-DMT. Experimental Neurology. Retrieved December 26, 2021. https://www.sciencedirect.com/science/article/abs/pii/S0014488620300078
Lancelotta, & Davis, A. K. (2020). Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects. Journal of Psychoactive Drugs, 52(3), 273–281. https://www.tandfonline.com/doi/abs/10.1080/02791072.2020.1737763?journalCode=ujpd20
Sherwood, Claveau, R., Lancelotta, R., Kaylo, K. W., & Lenoch, K. (2020). Synthesis and Characterization of 5‑MeO-DMT Succinate for Clinical Use. ACS Omega, 5(49), 32067–32075. https://pubs.acs.org/doi/10.1021/acsomega.0c05099
Uthaug, Lancelotta, R., van Oorsouw, K., Kuypers, K. P. ., Mason, N., Rak, J., Šuláková, A., Jurok, R., Maryška, M., Kuchař, M., Páleníček, T., Riba, J., & Ramaekers, J. . (2019). A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Psychopharmacology, 236(9), 2653–2666. https://link.springer.com/article/10.1007/s00213-019-05236-w
Davis, So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R. (2019). 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. The American Journal of Drug and Alcohol Abuse, 45(2), 161–169. https://www.tandfonline.com/doi/abs/10.1080/00952990.2018.1545024?journalCode=iada20
Lima da Cruz, Moulin, T. C., Petiz, L. L., & Leão, R. N. (2018). A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus. Frontiers in Molecular Neuroscience, 11, 312–312. https://www.frontiersin.org/articles/10.3389/fnmol.2018.00312/full
Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. (2018). The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption. Journal of Psychopharmacology, 32(7), 779-792. https://journals.sagepub.com/doi/abs/10.1177/0269881118769063
Cox, K. E., Moshman, S. A., Barsuglia, J. P., Lancelotta, R., & Davis, A. K. (2018). Subjective improvements in substance use problems following 5-MeO-DMT use in an international sample. Poster session presented at the Annual Poster Symposium of the Behavioral Pharmacology Research Unit, Baltimore, MD. https://www.researchgate.net/publication/326468791_Subjective_improvements_in_substance_use_problems_following_5-MeO-DMT_use_in_an_international_sample
Barsuglia, Davis, A. K., Palmer, R., Lancelotta, R., Windham-Herman, A.-M., Peterson, K., Polanco, M., Grant, R., & Griffiths, R. R. (2018). Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study. Frontiers in Psychology, 9, 2459–2459. https://five-meo.education/scientific-research/
Dakic, Minardi Nascimento, J., Costa Sartore, R., Maciel, R. de M., de Araujo, D. B., Ribeiro, S., Martins-de-Souza, D., & Rehen, S. K. (2017). Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. Scientific Reports, 7(1), 12863–13. https://www.nature.com/articles/s41598-017-12779-5
Szabo, Kovacs, A., Frecska, E., & Rajnavolgyi, E. (2014). Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells. PloS One, 9(8), e106533. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0106533
Halberstadt, Nichols, D. E., & Geyer, M. A. (2012). Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor. Psychopharmacology, 221(4), 709–718. https://link.springer.com/article/10.1007/s00213-011-2616-6
van den Buuse, M., Ruimschotel, E., Martin, S., Risbrough, V. B., & Halberstadt, A. L. (2011). Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT1A receptor knockout mice: implications for schizophrenia. Neuropharmacology, 61(1-2), 209-216. https://www.sciencedirect.com/science/article/abs/pii/S0028390811001468
Wojick, Langan, J. N., & Mitchell, M. A. (2010). Evaluation of MS-222 (Tricaine Methanesulfonate) and Propofol as Anesthetic Agents in Sonoran Desert Toads (Bufo alvarius). Journal of Herpetological Medicine and Surgery, 20(2), 79–83. https://bioone.org/journals/journal-of-herpetological-medicine-and-surgery/volume-20/issue-2/1529-9651-20.2.79/Evaluation-of-MS-222-Tricaine-Methanesulfonate-and-Propofol-as-Anesthetic/10.5818/1529-9651-20.2.79.short
Krebs-Thomson, Ruiz, E. M., Masten, V., Buell, M., & Geyer, M. A. (2006). The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats. Psychopharmacology, 189(3), 319–329. https://link.springer.com/article/10.1007/s00213-006-0566-1
Weil, A. T., & Davis, W. (2002, November 8). Bufo alvarius: A potent hallucinogen of animal origin. Journal of Ethnopharmacology. https://www.sciencedirect.com/science/article/abs/pii/0378874194900515
Stoff, D. M., Gorelick, D. A., Bozewicz, T., Bridger, W. H., Gillin, J. C., & Wyatt, R. J. (1978). The indole hallucinogens, N, N-dimethyltryptamine (DMT) and 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT), have different effects from mescaline on rat shuttlebox avoidance. Neuropharmacology, 17(12), 1035-1040. https://www.sciencedirect.com/science/article/abs/pii/0028390878900308
Acosta-Urquidi, Juan. (2018). EEG studies of the acute effects of 5-MeO- DMT. WBAC, CDMX July 27-29, 2018.
Timmermann, C., Roseman, L., Schartner, M. et al. Neural correlates of the DMT experience assessed with multivariate EEG. Sci Rep 9, 16324 (2019). https://doi.org/10.1038/s41598-019-51974-4
https://uploads-ssl.webflow.com/5dab753665b2d985ff08d69b/5dab753665b2d92d7808d6d1_Best%20Practices%20Outline%20(Finalv9).pdf 5-MEO-DMT A Recommended Model for Best Practices from The Conclave
https://uploads-ssl.webflow.com/5dab753665b2d985ff08d69b/5dab753665b2d9a3bd08d6e9_Conclave_Ethical%20Commitments.v.1.4.pdf The Conclave Ethical Commitments